In this study, we firstly used full spectrum flow cytometry to comprehensive analyze the peripheral blood immune cells in EGFR-TKI-resistant NSCLC patients receiving ICI plus chemotherapy, and identified 19 subsets of immune cells and 6 kinds of ICPs expression on each subset. Here, EGFR is linked to non-small cell lung carcinoma.